Familial dilated cardiomyopathy (DCM) is a disease characterized by dilation of the heart chambers and its structural dysfunction. This disease can be inherited and is caused by genetic factors, which makes it familial in nature. The main mechanism leading to the development of the disease is the violation of myocardial remodeling, which leads to a decrease in the contractility of the heart, and, consequently, to the development of heart failure. Symptoms include shortness of breath, fatigue, edema, and arrhythmia. This form of cardiomyopathy often requires a comprehensive approach to diagnosis and treatment, including both drug and non-drug methods.
History of the disease and interesting historical facts
Familial dilated cardiomyopathy has been a subject of medical research since the late 19th century, when scientists began to notice a connection between the clinical manifestations of heart disease and genetics. In the 1980s, cases of hereditary DCM were first described, which made it possible to identify a group of patients with a familial predisposition to this disease. It was then that gene mutations associated with DCM were discovered, which opened up new horizons in understanding the pathogenesis of the disease. Research continued in the 21st century, when the development of molecular genetic diagnostic methods made it possible to more accurately identify patients and determine their genetic predisposition.
Epidemiology
Epidemiological data indicate that the prevalence of dilated cardiomyopathy varies by geographic region and ethnicity. Estimates indicate that pre-existing cases occur in 5-8 cases per 100,000 population. However, in some populations, particularly those with a family history of the disease, the figure may be as high as 30 per 100,000. This highlights the importance of screening and early detection among the most vulnerable populations.
Genetic predisposition to this disease
Studies show that more than 30% cases of dilated cardiomyopathy are hereditary. The main genes involved include LMNA, TTN, MYH7 and others, which is confirmed by numerous studies. For example, mutations in the TTN gene, which encodes the titin protein, are associated with the occurrence of DCM and lead to significant changes in the structure of the myocardium. In addition, genetic studies also show that not all patients with mutations exhibit clinical symptoms, indicating the complexity of interactions between genetic and environmental factors.
Risk factors for the development of this disease
Among the main risk factors that contribute to the development of familial dilated cardiomyopathy are:
- Family history of cardiovascular disease
- Presence of other cardiomyopathies
- Autoimmune diseases
- Uncontrolled infectious diseases
- The influence of toxic substances and some drugs
- Drinking alcohol in large quantities
- Physical activity and heart injury
Diagnosis of this disease
Diagnosis of familial dilated cardiomyopathy involves several stages. The main symptoms to look out for are:
- Shortness of breath, especially with physical exertion
- Feeling tired
- Swelling of the extremities
- Heart palpitations or arrhythmia
Laboratory tests may include blood tests for levels of natriuretic peptides, which may be elevated in heart failure. Radiologic tests, such as echocardiography and magnetic resonance imaging, can visualize changes in the structure of the heart. Other tests, such as an electrocardiogram (ECG) and Holter monitoring, can help evaluate heart rhythm and function. The most important aspect of diagnosis is the differential diagnosis, which involves ruling out other causes of heart failure, such as coronary artery disease or hypertensive cardiomyopathy.
Treatment
Treatment of familial dilated cardiomyopathy requires a comprehensive approach and can be either medical or surgical. General recommendations include:
- Reducing physical activity
- Lifestyle changes with an emphasis on a balanced diet and avoiding bad habits
Pharmacological treatment may include:
- Angiotensin-converting enzyme (ACE) inhibitors
- Beta blockers
- Diuretics to reduce swelling
Surgical treatment may be indicated in the form of a heart transplant or defibrillator placement if the risk of arrhythmia is high. It is also recommended to consider participation in clinical trials of new therapies.
List of medications used to treat this disease
Among the drugs used, the following can be distinguished:
- Enalapril (ACE inhibitor)
- Carvedilol (beta blocker)
- Furosemide (diuretic)
- Spironolactone (potassium-sparing diuretic)
- Digoxin (to control heart rhythm)
Disease monitoring
Monitoring of patients with familial dilated cardiomyopathy involves regular observation and monitoring of clinical symptoms, functional capacity, and overall cardiovascular health. Monitoring steps may include:
- Regular ECG and echocardiographic examinations
- Evaluation of the level of natriuretic peptides in the blood
- Blood pressure and heart rate monitoring
The prognosis of the disease may vary depending on the patient's condition and the presence of comorbidities. Patients with gene mutations associated with cardiomyopathy have a significantly increased risk of complications such as blood clots, arrhythmia, and heart failure.
Age-related features of the disease
Familial dilated cardiomyopathy can occur in different age groups:
- In children, the disease often manifests itself acutely, with severe clinical manifestations and a high probability of heart failure.
- In young people, the disease may be asymptomatic in the early stages, making diagnosis difficult.
- In old age, clinical manifestations may be less pronounced, but the risk of complications increases.
Questions and Answers
- What are the main symptoms of familial dilated cardiomyopathy? The main symptoms are shortness of breath, fatigue, swelling and arrhythmia.
- Is it possible to completely cure this disease? Familial DCM is considered a chronic condition and cannot be completely cured, but the disease can be controlled.
- What is the role of genetic testing? Genetic testing helps identify mutations associated with a disease and determines the risk of disease in family members.
- What factors increase the risk of disease? Major risk factors include family history, presence of other cardiovascular diseases, and exposure to toxic substances.
- How often should you undergo examinations? It is recommended to undergo examinations at least once every six months, including ECG and echocardiography.
Advice from Dr. Oleg Korzhikov
“Patients with familial dilated cardiomyopathy should remember the importance of regular monitoring and following all recommendations of doctors. Even in the absence of pronounced symptoms, it is necessary to avoid strenuous physical activity and control stress levels. It is also important not to neglect a healthy lifestyle, follow a diet and avoid alcohol. In case of sudden deterioration of the condition, it is necessary to seek medical help immediately. Also, if someone in the family has been diagnosed with DCM, it is worth discussing the possibility of genetic testing for early detection of the disease in other family members. This gives a chance for more effective treatment and prevention of serious complications.”
